Beijing Wantai Biological's Bivalent HPV Vaccine Gains Market Access in Multiple Southeast Asian Countries

Deep News2025-12-15

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SH) announced on December 15 that its bivalent HPV vaccine has obtained market access in several Southeast Asian countries, including Cambodia, Thailand, Myanmar, and Indonesia. The company made this statement in response to an investor inquiry on an interactive platform regarding its plans for promoting cervical cancer vaccines in Southeast Asia.

Additionally, Beijing Wantai Biological stated that its nonavalent HPV vaccine will leverage the international achievements of the bivalent HPV vaccine to establish a broader global network, further supporting the worldwide strategy to eliminate cervical cancer.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1156739069?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-15 18:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156739069","market":"us","top_or_hot":-1,"title":"Beijing Wantai Biological's Bivalent HPV Vaccine Gains Market Access in Multiple Southeast Asian Countries","media":"Deep News","content":"<p>Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SH) announced on December 15 that its bivalent HPV vaccine has obtained market access in several Southeast Asian countries, including Cambodia, Thailand, Myanmar, and Indonesia. The company made this statement in response to an investor inquiry on an interactive platform regarding its plans for promoting cervical cancer vaccines in Southeast Asia.</p>\n<p>Additionally, Beijing Wantai Biological stated that its nonavalent HPV vaccine will leverage the international achievements of the bivalent HPV vaccine to establish a broader global network, further supporting the worldwide strategy to eliminate cervical cancer.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beijing Wantai Biological's Bivalent HPV Vaccine Gains Market Access in Multiple Southeast Asian Countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeijing Wantai Biological's Bivalent HPV Vaccine Gains Market Access in Multiple Southeast Asian Countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2025-12-15 18:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SH) announced on December 15 that its bivalent HPV vaccine has obtained market access in several Southeast Asian countries, including Cambodia, Thailand, Myanmar, and Indonesia. The company made this statement in response to an investor inquiry on an interactive platform regarding its plans for promoting cervical cancer vaccines in Southeast Asia.</p>\n<p>Additionally, Beijing Wantai Biological stated that its nonavalent HPV vaccine will leverage the international achievements of the bivalent HPV vaccine to establish a broader global network, further supporting the worldwide strategy to eliminate cervical cancer.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"603392","symbol_name":"万泰生物","start_time":0,"source_url":"","article_id":"1156739069","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156739069","pubTimestamp":1765792877,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SH) announced on December 15 that its bivalent HPV vaccine has obtained market access in several Southeast Asian countries, including...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159646":"疫苗","603392":"万泰生物","LU1981816686.USD":"EASTSPRING INV ASIAN MULTI FACTOR EQUITY \"A\" (USD) ACC","BK1589":"北水核心资产","BK1200":"软饮料","09633":"农夫山泉","BK0239":"医药制造"},"translate_title":"北京万泰生物二价HPV疫苗获东南亚多国市场准入","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159646":1,"603392":1,"09633":1},"content_text":"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SH) announced on December 15 that its bivalent HPV vaccine has obtained market access in several Southeast Asian countries, including Cambodia, Thailand, Myanmar, and Indonesia. The company made this statement in response to an investor inquiry on an interactive platform regarding its plans for promoting cervical cancer vaccines in Southeast Asia.\nAdditionally, Beijing Wantai Biological stated that its nonavalent HPV vaccine will leverage the international achievements of the bivalent HPV vaccine to establish a broader global network, further supporting the worldwide strategy to eliminate cervical cancer.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1156739069","isCrawlerRequest":true}